Ovarian Function and Fertility Preservation in Breast Cancer: Should Gonadotropin-Releasing Hormone Agonist be administered to All Premenopausal Patients Receiving Chemotherapy?

Chemotherapy-induced premature ovarian insufficiency (POI) is one of the potential drawbacks of chemotherapy use of particular concern for newly diagnosed premenopausal breast cancer patients. Temporary ovarian suppression obtained pharmacologically with the administration of a gonadotropin-releasin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambertini, Matteo, Richard, François, Nguyen, Bastien, Viglietti, Giulia, Villarreal-Garza, Cynthia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410390/
https://www.ncbi.nlm.nih.gov/pubmed/30886529
http://dx.doi.org/10.1177/1179558119828393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410390/
https://www.ncbi.nlm.nih.gov/pubmed/30886529
http://dx.doi.org/10.1177/1179558119828393

Ejemplares similares